Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

SELL
$8.24 - $12.56 $8,240 - $12,560
-1,000 Reduced 62.11%
610 $5,000
Q2 2022

Aug 04, 2022

BUY
$7.45 - $13.84 $2,086 - $3,875
280 Added 21.05%
1,610 $14,000
Q4 2021

Jan 18, 2022

SELL
$11.99 - $18.14 $12,169 - $18,412
-1,015 Reduced 43.28%
1,330 $16,000
Q3 2021

Oct 26, 2021

BUY
$11.55 - $16.06 $27,084 - $37,660
2,345 New
2,345 $36,000
Q3 2020

Oct 27, 2020

SELL
$12.34 - $17.92 $37,020 - $53,760
-3,000 Closed
0 $0
Q1 2020

May 07, 2020

BUY
$9.12 - $17.78 $21,924 - $42,743
2,404 Added 403.36%
3,000 $39,000
Q4 2019

Feb 06, 2020

SELL
$16.11 - $25.98 $11,277 - $18,186
-700 Reduced 54.01%
596 $9,000
Q3 2019

Oct 28, 2019

SELL
$18.28 - $26.91 $25,592 - $37,674
-1,400 Reduced 51.93%
1,296 $23,000
Q2 2019

Aug 09, 2019

BUY
$17.68 - $21.57 $31,824 - $38,826
1,800 Added 200.89%
2,696 $57,000
Q1 2019

May 10, 2019

BUY
$14.41 - $19.64 $7,205 - $9,820
500 Added 126.26%
896 $17,000
Q4 2018

Feb 05, 2019

SELL
$12.45 - $23.47 $4,980 - $9,388
-400 Reduced 50.25%
396 $5,000
Q3 2018

Nov 07, 2018

BUY
$17.57 - $23.95 $3,514 - $4,790
200 Added 33.56%
796 $19,000
Q2 2018

Aug 10, 2018

SELL
$11.6 - $19.27 $32,480 - $53,956
-2,800 Reduced 82.45%
596 $11,000
Q1 2018

May 11, 2018

BUY
$11.77 - $16.08 $15,253 - $20,839
1,296 Added 61.71%
3,396 $42,000
Q4 2017

Jan 17, 2018

SELL
$11.86 - $14.08 $2,372 - $2,816
-200 Reduced 8.7%
2,100 $25,000
Q3 2017

Oct 17, 2017

BUY
$12.6 - $16.34 $28,980 - $37,582
2,300
2,300 $31,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $15M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.